Details of Drug

Drug General Information (ID: D0902)
Drug Name	Lenalidomide
Drug Type	Small molecule
Drug Synonymous	Revamid; Revimid; Revlimid; Celgene brand of lenalidomide; Lenalidomide [USAN]; CC 5013; CC5013; CDC 501; IMiD3; IMiD3cpd; ALBB-015321; CC-5013; CDC-501; CDC-5013; ENMD-0997; IMID-5013; Revlimid (Celgene); Revlimid (TN); Thalidomide analog CC-5013; Lenalidomide (USAN/INN); CC-5013, Revlimid, Lenalidomide; 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione; 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; 3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione; 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione; Lenalidomide (Immunomodulator) Click to Show/Hide
Disease Class	2A83: Multiple myeloma
Therapeutic Class	Antineoplastics
Structure
Structure	3D Structure		2D Structure
Formula	C13H13N3O3
InChI	1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)
InChIKey	GOTYRUGSSMKFNF-UHFFFAOYSA-N
Canonical SMILES	C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N
External Link
	Pubchem ID	216326
	CAS Number	191732-72-6
	CHEBI ID	63791
	TTD ID	D0Q5NX
	VARIDT ID	DR00261

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM002 Affected cellular transport AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM010 Transporter inhibition BM011 Transporter induction BM043 Additive immunosuppressive effects BM044 Additive myelosuppressive effects BM047 Additive thrombogenic effects BM055 Increased risk of hepatotoxicity BM100 Antagonize the effect of vaccine/toxoid BM105 Antagonize the effect of probiotics BM106 Diminish the response to diagnostic skin test antigens BM107 Attenuated pharmacological effects (Unspecific) BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Lenalidomide
Affected cellular transport
	Transporter inhibition					Drug Num: 13
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0044		Alpelisib	C19H22F3N5O2S	56649450	Moderate		Inter Info	[7], [61], [62]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[7], [71], [72]
D0251		Capmatinib	C23H17FN6O	25145656	Moderate		Inter Info	[77]
D0408		Daclatasvir	C40H50N8O6	25154714	Moderate		Inter Info	[7], [78]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[7], [83]
D0590		Erdafitinib	C25H30N6O2	67462786	Moderate		Inter Info	[86]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[87]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Moderate		Inter Info	[7]
D0897		Lasmiditan	C19H18F3N3O2	11610526	Moderate		Inter Info	[91]
D0898		Ledipasvir	C49H54F2N8O6	67505836	Moderate		Inter Info	[92]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[7]
D1136		Nilotinib	C28H22F3N7O	644241	Moderate		Inter Info	[95]
D1660		Tucatinib	C26H24N8O2	51039094	Moderate		Inter Info	[113]
	Transporter induction					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0095		Apalutamide	C21H15F4N5O2S	24872560	Moderate		Inter Info	[7], [65]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[84], [19], [7], [85]
Pharmacodynamic additive effects
	Additive immunosuppressive effects					Drug Num: 33
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0023		Adalimumab	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0348		Cladribine	C10H12ClN5O3	20279	Major		Inter Info	[7], [10]
D0614		Etanercept	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0146		Baricitinib	C16H17N7O2S	44205240	Major		Inter Info	[19], [7], [20]
D0304		Certolizumab pegol	NA	NA	Major		Inter Info	[1], [5], [6]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[23]
D0736		Golimumab	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[7], [26]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[19], [29]
D1600		Tofacitinib	C16H20N6O	9926791	Major		Inter Info	[33]
D1666		Upadacitinib	C17H19F3N6O	58557659	Major		Inter Info	[34]
D1111		Natalizumab	NA	NA	Major		Inter Info	[35]
D0033		Alemtuzumab	NA	NA	Moderate		Inter Info	[36]
D0085		Anakinra	C20H23N5O7S2	146171046	Moderate		Inter Info	[37], [38], [39]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[19], [7], [51]
D0314		Chloramphenicol (ophthalmic)	C11H12Cl2N2O5	5959	Moderate		Inter Info	[19], [7], [51]
D0553		Efalizumab	NA	NA	Moderate		Inter Info	[52]
D0136		Azathioprine	C9H7N7O2S	2265	Moderate		Inter Info	[19], [7]
D0246		Canakinumab	NA	NA	Moderate		Inter Info	[37], [38], [39]
D0443		Denosumab	NA	NA	Moderate		Inter Info	[79]
D0507		Diroximel fumarate	C11H13NO6	73330464	Moderate		Inter Info	[80]
D1085		Monomethyl fumarate	C5H6O4	5369209	Moderate		Inter Info	[80]
D1140		Niraparib	C19H20N4O	24958200	Moderate		Inter Info	[96]
D1162		Ocrelizumab	NA	NA	Moderate		Inter Info	[97]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[7], [98]
D1174		Omacetaxine mepesuccinate	C29H39NO9	285033	Moderate		Inter Info	[99]
D1375		Radium Ra 223 dichloride	NA	NA	Moderate		Inter Info	[107]
D1403		Rilonacept	NA	NA	Moderate		Inter Info	[37], [38], [39]
D1422		Roflumilast	C17H14Cl2F2N2O3	449193	Moderate		Inter Info	[7], [108]
D1487		Sodium phosphate, monobasic (p32)	NA	NA	Moderate		Inter Info	[110]
D1509		Strontium chloride Sr-89	Cl2Sr	5388879	Moderate		Inter Info	[19], [7], [111]
D1720		Zidovudine	C10H13N5O4	35370	Moderate		Inter Info	[19], [7], [114]
D1855		Palifermin	NA	NA	Moderate		Inter Info	[116]
	Additive myelosuppressive effects					Drug Num: 5
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[7], [11], [12]
D0433		Deferiprone	C7H9NO2	2972	Major		Inter Info	[19], [21], [8]
D1443		Samarium (153Sm) lexidronam	Sm	23951	Major		Inter Info	[28]
D0710		Ganciclovir	C9H13N5O4	135398740	Moderate		Inter Info	[19], [7], [88], [89]
D1676		Valganciclovir	C14H22N6O5	135413535	Moderate		Inter Info	[19], [7], [88], [89]
	Additive thrombogenic effects					Drug Num: 23
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0387		Conjugated estrogens	C18H21NaO5S	45357473	Major		Inter Info	[7], [13], [8]
D0388		Conjugated estrogens (topical)	C18H21NaO5S	45357473	Major		Inter Info	[7], [13], [8]
D0423		Darbepoetin alfa	NA	NA	Major		Inter Info	[7], [13], [8]
D0487		Diethylstilbestrol	C18H20O2	448537	Major		Inter Info	[7], [13], [8]
D0598		Erythropoietin	C22H22ClKN6O	11751549	Major		Inter Info	[7], [13], [8]
D0385		Conestat alfa	NA	NA	Major		Inter Info	[7], [13], [8]
D0484		Dienestrol (topical)	C18H18O2	667476	Major		Inter Info	[7], [13], [8]
D0536		Drospirenone	C24H30O3	68873	Major		Inter Info	[7], [22], [13]
D0605		Esterified estrogens	NA	NA	Major		Inter Info	[7], [13], [8]
D0606		Estradiol	C18H24O2	5757	Major		Inter Info	[7], [13], [8]
D0607		Estradiol (topical)	C18H24O2	5757	Major		Inter Info	[7], [13], [8]
D0609		Estrone	C18H22O2	5870	Major		Inter Info	[7], [13], [8]
D0610		Estrone sulfate	C18H22O5S	3001028	Major		Inter Info	[7], [13], [8]
D0611		Estrone sulfate (topical)	C18H22O5S	3001028	Major		Inter Info	[7], [13], [8]
D0619		Ethinylestradiol	C20H24O2	5991	Major		Inter Info	[7], [22], [13]
D0762		Human C1-esterase inhibitor	NA	NA	Major		Inter Info	[7], [13], [8]
D1011		Mestranol	C21H26O2	6291	Major		Inter Info	[7], [22], [13]
D1191		Ospemifene	C24H23ClO2	3036505	Major		Inter Info	[7], [13], [8]
D1236		Peginesatide	NA	NA	Major		Inter Info	[7], [13], [8]
D1370		Quinestrol	C25H32O2	9046	Major		Inter Info	[7], [13], [8]
D1376		Raloxifene	C28H27NO4S	5035	Major		Inter Info	[7], [13], [8]
D1533		Tamoxifen	C26H29NO	2733526	Major		Inter Info	[7], [13], [8]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[7], [13], [8]
	Increased risk of hepatotoxicity					Drug Num: 21
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[24]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[25]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[27]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[24]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[40], [41], [42], [19], [7], [43], [44], [45], [46], [47], [48], [49], [50]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[19], [7], [53]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[57], [58], [59], [60]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[57], [58], [59], [60]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[40], [41], [42], [19], [7], [43], [44], [45], [46], [47], [48], [49], [50]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Moderate		Inter Info	[66]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[70]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[40], [41], [42], [19], [7], [43], [44], [45], [46], [47], [48], [49], [50]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[7], [76]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[81], [82]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[90]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[7], [93]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[94]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[57], [58], [59], [60]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[7], [112]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[40], [41], [42], [19], [7], [43], [44], [45], [46], [47], [48], [49], [50]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[119], [120]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 14
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0303		Cerivastatin	C26H34FNO5	446156	Major		Inter Info	[7], [8], [9]
D0118		Atezolizumab	NA	NA	Major		Inter Info	[14], [15], [13]
D0120		Atorvastatin	C33H35FN2O5	60823	Major		Inter Info	[7], [8], [9]
D1742		Avelumab	NA	NA	Major		Inter Info	[14], [15], [13]
D0541		Durvalumab	NA	NA	Major		Inter Info	[14], [15], [13]
D0686		Fluvastatin	C24H26FNO4	446155	Major		Inter Info	[7], [8], [9]
D1150		Nivolumab	NA	NA	Major		Inter Info	[14], [15], [13]
D1240		Pembrolizumab	NA	NA	Major		Inter Info	[14], [15], [13]
D1301		Pitavastatin	C25H24FNO4	5282452	Major		Inter Info	[7], [8], [9]
D1430		Rosuvastatin	C22H28FN3O6S	446157	Major		Inter Info	[7], [8], [9]
D1473		Simvastatin	C25H38O5	54454	Major		Inter Info	[7], [8], [9]
D0956		Lovastatin	C24H36O5	53232	Major		Inter Info	[7], [8], [9]
D1329		Pravastatin	C23H36O7	54687	Major		Inter Info	[7], [8], [9]
D1426		Romosozumab	NA	NA	Moderate		Inter Info	[109]
Pharmacodynamic antagonistic effects
	Antagonize the effect of vaccine/toxoid					Drug Num: 22
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1744		Bacillus calmette-guerin substrain tice live antigen	NA	NA	Major		Inter Info	[16], [17], [18]
D1839		Measles virus vaccine live attenuated	NA	NA	Major		Inter Info	[16], [17], [18]
D1849		Mumps virus strain B level jeryl lynn live antigen	NA	NA	Major		Inter Info	[16], [17], [18]
D1881		Rotavirus vaccine	NA	NA	Major		Inter Info	[16], [17], [18]
D1882		Rubella virus vaccine	NA	NA	Major		Inter Info	[16], [17], [18]
D1890		Smallpox (Vaccinia) Vaccine, Live	NA	NA	Major		Inter Info	[30], [19], [31]
D1897		Talimogene laherparepvec	NA	NA	Major		Inter Info	[32]
D1914		Typhoid vaccine (live)	NA	NA	Major		Inter Info	[16], [17], [18]
D1920		Varicella Zoster Vaccine (Recombinant)	NA	NA	Major		Inter Info	[16], [17], [18]
D1922		Yellow Fever Vaccine	NA	NA	Major		Inter Info	[16], [17], [18]
D0089		Anthrax vaccine	NA	NA	Moderate		Inter Info	[30], [63], [64]
D0366		Clostridium tetani toxoid antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[30], [63], [64]
D0756		Hepatitis B Vaccine (Recombinant)	NA	NA	Moderate		Inter Info	[30], [63], [64]
D0767		Human papillomavirus type 11 L1 capsid protein antigen	NA	NA	Moderate		Inter Info	[30], [63], [64]
D0803		Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated)	NA	NA	Moderate		Inter Info	[30], [63], [64]
D0804		Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[30], [63], [64]
D0999		Meningococcal polysaccharide vaccine group C	NA	NA	Moderate		Inter Info	[30], [63], [64]
D1259		Pfizer-BioNTech Covid-19 Vaccine	NA	NA	Moderate		Inter Info	[100], [30], [19], [101], [102], [103], [63], [104], [105], [106], [64]
D1307		Poliovirus type 1 antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[30], [63], [64]
D1662		Typhoid vaccine (inactivated)	NA	NA	Moderate		Inter Info	[30], [63], [64]
D1692		Vibrio cholerae CVD 103-HgR strain live antigen	NA	NA	Moderate		Inter Info	[30], [63], [64]
D1838		Lyme disease vaccine (recombinant OspA)	NA	NA	Moderate		Inter Info	[115]
	Antagonize the effect of probiotics					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1749		Bifidobacterium longum infantis	NA	NA	Moderate		Inter Info	[67], [68], [69]
	Diminish the response to diagnostic skin test antigens					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1755		Candida albicans	C29H27N2O12P	118855431	Moderate		Inter Info	[73], [74], [75]
D1765		Coccidioides immitis spherule	NA	NA	Moderate		Inter Info	[73], [74], [75]
D1912		Trichophyton mentagrophytes	NA	NA	Moderate		Inter Info	[73], [74], [75]
D1913		Tuberculin purified protein derivative	NA	NA	Moderate		Inter Info	[73], [74], [75]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0659		Filgrastim	NA	NA	Moderate		Inter Info	[54], [55], [56]
D1235		Pegfilgrastim	C27H46N4O19	70683024	Moderate		Inter Info	[117], [118]
D1446		Sargramostim	NA	NA	Moderate		Inter Info	[54], [55], [56]

References
1	Product Information. Cimzia (certolizumab). UCB Pharma Inc, Smyrna, GA.
2	Product Information. Enbrel (etanercept). Wyeth-Ayerst Laboratories, Philadelphia, PA.
3	Product Information. Humira (adalimumab). Abbott Pharmaceutical, Abbott Park, IL.
4	Product Information. Remicade (infliximab). Centocor Inc, Malvern, PA.
5	Product Information. Simponi (golimumab). Centocor Inc, Malvern, PA.
6	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Drug labels for the Tumor Necrosis Factor-alpha (TNFa) blockers now include warnings about infection with Legionella and Listeria bacteria. ".
7	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
8	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
9	EMA. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP) "Revlimid."
10	Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
11	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
12	Canadian Pharmacists Association "e-CPS."
13	Product Information. Revlimid (lenalidomide). Celgene Corporation, Summit, NJ.
14	Product Information. Pomalyst (pomalidomide). QLT Phototherapeutics Inc, Vancouver, AZ.
15	Product Information. Keytruda (pembrolizumab). Merck &amp Company Inc, Whitehouse Station, NJ.
16	Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. "Harrison's Principles of Internal Medicine. 14th ed." New York, NY: McGraw-Hill Health Professionals Division (1998).
17	Product Information. Attenuvax (measles virus vaccine, live, attenuated). Merck &amp Co, Inc, West Point, PA.
18	Product Information. YF-Vax (yellow fever vaccine). sanofi pasteur, Swiftwater, PA.
19	Cerner Multum, Inc. "Australian Product Information.".
20	Product Information. Olumiant (baricitinib). Lilly, Eli and Company, Indianapolis, IN.
21	Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
22	Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
23	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
24	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
25	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
26	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
27	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
28	Product Information. Quadramet (samarium sm 153 lexidronam) Berlex Laboratories, Richmond, CA.
29	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
30	CDC. Centers for Disease Control and Prevention/ "Recommendations of the advisory committtee on immunization practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence." MMWR Morb Mortal Wkly Rep 42(RR-04) (1993): 1-18. [PMID: 20300058]
31	Product Information. Dryvax (smallpox vaccine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
32	Product Information. Imlygic (talimogene laherparepvec). Amgen USA, Thousand Oaks, CA.
33	Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
34	Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
35	Product Information. Tysabri (natalizumab). Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.
36	Product Information. Campath (alemtuzumab) Berlex, Richmond, CA.
37	Product Information. Arcalyst (rilonacept). Regeneron Pharmaceuticals Inc, Tarrytown, NY.
38	Product Information. Ilaris (canakinumab). Novartis Pharmaceuticals, East Hanover, NJ.
39	Product Information. Kineret (anakinra). Amgen, Thousand Oaks, CA.
40	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
41	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
42	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
43	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
44	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
45	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
46	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
47	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
48	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
49	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
50	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
51	Sim SM, Back DJ, Breckenridge AM "The effect of various drugs on the glucuronidation of zidovudine (azidothymidine AZT) by human liver microsomes." Br J Clin Pharmacol 32 (1991): 17-21. [PMID: 1909542]
52	Product Information. Raptiva (efalizumab). Genentech, South San Francisco, CA.
53	Product Information. Ellence (epirubicin) Pharmacia and Upjohn, Kalamazoo, MI.
54	Product Information. Granix (tbo-filgrastim). Teva Pharmaceuticals USA, North Wales, PA.
55	Product Information. Leukine (sargramostim). Immunex Corporation, Seattle, WA.
56	Product Information. Stemgen (ancestim) Amgen, Thousand Oaks, CA.
57	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
58	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
59	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
60	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
61	Product Information. Diovan (valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
62	Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
63	Product Information. Imovax Rabies (rabies vaccine). sanofi pasteur, Swiftwater, PA.
64	Department of Health. National Health Service "Immunisation Against Infectious Disease - "The Green Book". Chapter 6: Contraindications and special considerations.".
65	Product Information. Erleada (apalutamide). Janssen Biotech, Inc., Horsham, PA, PA.
66	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
67	Borriello SP, Hammes WP, Holzapfel W, et.al "Safety of probiotics that contain lactobacilli or bifidobacteria." Clin Infect Dis 36 (2003): 775-80. [PMID: 12627362]
68	Schlegel L, Lemerle S, Geslin P "Lactobacillus species as opportunistic pathogens in immunocompromised patients." Eur J Clin Microbiol Infect Dis 17 (1998): 887-8. [PMID: 10052559]
69	Salminen MK, Tynkkynen S, Rautelin H, et al. "Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland." Clin Infect Dis 35 (2002): 1155-60. [PMID: 12410474]
70	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
71	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
72	Product Information. Lonsurf (tipiracil-trifluridine). Taiho Oncology, Inc., Princeton, NJ.
73	Product Information. Tuberculin PPD (Mantoux) (tuberculin purified protein derivative). Connaught Laboratories Ltd, Toronto, ON.
74	Product Information. Candin (candida albicans extract). Nielsen Biosciences Inc, San Diego, CA.
75	Product Information. Spherulin (coccidioidin skin test). ALK Laboratories Inc, Wallingford, CT.
76	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
77	Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
78	Product Information. Daklinza (daclatasvir). Bristol-Myers Squibb, Princeton, NJ.
79	Product Information. Prolia (denosumab). Amgen USA, Thousand Oaks, CA.
80	Product Information. Vumerity (diroximel fumarate). Alkermes, Inc, Cambridge, MA.
81	Elsharkawy AM, Schwab U, McCarron B, et al. "Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser." J Clin Virol 58 (2013): 331-3. [PMID: 23763943]
82	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
83	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
84	Benoist G, van Oort I, et al "Drug-drug interaction potential in men treated with enzalutamide: Mind the gap." Br J Clin Pharmacol 0 (2017): epub. [PMID: 28881501]
85	Product Information. Xtandi (enzalutamide). Astellas Pharma US, Inc, Deerfield, IL.
86	Product Information. Balversa (erdafitinib). Janssen Products, LP, Horsham, PA.
87	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
88	Product Information. Cytovene (ganciclovir). Genentech, South San Francisco, CA.
89	Product Information. Valcyte (valganciclovir) Roche Laboratories, Nutley, NJ.
90	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
91	Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
92	Product Information. Harvoni (ledipasvir-sofosbuvir). Gilead Sciences, Foster City, CA.
93	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
94	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
95	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
96	Product Information. Zejula (niraparib). Tesaro Inc., Waltham, MA.
97	Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.
98	Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
99	Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
100	CDC Centers for Disease Control and Prevention "General Best Practice Guidelines for Immunization: Altered Immunocompetence." .
101	Product Information. Biothrax (anthrax vaccine adsorbed). Emergent BioSolutions Inc., Lansing, MI.
102	Product Information. Fluzone Influenza Vaccine (influenza virus vaccine). Connaught, Swiftwater, PA.
103	Product Information. Havrix (hepatitis A vaccine). SmithKline Beecham, Philadelphia, PA.
104	Product Information. Influenza Virus Vaccine, H5N1, Inactivated (influenza virus vaccine, H5N1, inactivated). GlaxoSmithKline, Research Triangle Park, NC.
105	Product Information. Omnihib (haemophilus b conjugate vaccine). SmithKline Beecham, Philadelphia, PA.
106	CDC Centers for Disease Control and Prevention "Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States.".
107	Product Information. Xofigo (radium Ra 223 dichloride). Bayer Pharmaceutical Inc, West Haven, CT.
108	Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
109	Product Information. Evenity (romosozumab). Amgen USA, Thousand Oaks, CA.
110	AnazaoHealth Corporation "P32 Sodium Phosphate."
111	Multum Information Services, Inc. Expert Review Panel.
112	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
113	Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
114	Product Information. Retrovir (zidovudine). Glaxo Wellcome, Research Triangle Park, NC.
115	Shen AK, Mead PS, Beard CB. The Lyme disease vaccine--a public health perspective. Clin Infect Dis. 2011;52 Suppl 3:s247-s252. [PMID: 21217171]
116	Product Information. Kepivance (palifermin). Shire US Inc, Florence, KY.
117	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
118	Product Information. Neulasta (pegfilgrastim). Amgen, Thousand Oaks, CA.
119	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
120	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence